TY  - GEN
AU  - Delgado Sanchez, Olga
AU  - Gutierrez, Antonio
AU  - Do Pazo Oubina, Fernando
AU  - Gines, Jordi
AU  - Martorell, Clara
AU  - Boyeras, Barbara
AU  - Bento, Leyre
AU  - Garcia Recio, Marta
AU  - Sampol Mayol, Antonia
PY  - 2019
DO  - 10.2147/CEOR.S212257
SN  - 1178-6981
UR  - https://hdl.handle.net/20.500.12105/22677
AB  - Purpose: The availability of different routes of administration of rituximab, with different dosing and times of infusion in the day care unit, raises the question of which formulation would be the best in terms of direct cost, particularly with the...
LA  - eng
PB  - Dove Medical Press
KW  - Cost analysis
KW  - Rituximab
KW  - Intravenous
KW  - Subcutaneous
KW  - Biosimilar
TI  - Comparative Cost Analysis Of Intravenous And Subcutaneous Administration Of Rituximab In Lymphoma Patients
TY  - research article
ER  -